Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Machine Learning-Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation.
Sato M, Tateishi R, Moriyama M, Fukumoto T, Yamada T, Nakagomi R, Kinoshita MN, Nakatsuka T, Minami T, Uchino K, Enooku K, Nakagawa H, Shiina S, Ninomiya K, Kodera S, Yatomi Y, Koike K. Sato M, et al. Among authors: uchino k. Gastro Hep Adv. 2022 Feb 3;1(1):29-37. doi: 10.1016/j.gastha.2021.09.003. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39129938 Free PMC article.
Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation.
Sato M, Moriyama M, Fukumoto T, Yamada T, Wake T, Nakagomi R, Nakatsuka T, Minami T, Uchino K, Enooku K, Nakagawa H, Shiina S, Koike K, Fujishiro M, Tateishi R. Sato M, et al. Among authors: uchino k. Hepatol Int. 2024 Feb;18(1):131-137. doi: 10.1007/s12072-023-10585-y. Epub 2023 Sep 9. Hepatol Int. 2024. PMID: 37689614 Free PMC article.
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K. Shiina S, et al. Among authors: uchino k. Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578. doi: 10.1038/ajg.2011.425. Epub 2011 Dec 13. Am J Gastroenterol. 2012. PMID: 22158026 Free PMC article.
IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal.
Okushin K, Asaoka Y, Fukuda I, Fujiwara N, Minami T, Sato M, Mikami S, Uchino K, Enooku K, Kondo Y, Tateishi R, Goto T, Shiina S, Yoshida H, Koike K. Okushin K, et al. Among authors: uchino k. Case Rep Gastroenterol. 2012 Sep;6(3):784-9. doi: 10.1159/000346462. Epub 2012 Dec 22. Case Rep Gastroenterol. 2012. PMID: 23341802 Free PMC article.
CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.
Ohki T, Tateishi R, Akahane M, Mikami S, Sato M, Uchino K, Arano T, Enooku K, Kondo Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Matsuyama Y, Omata M, Ohtomo K, Koike K. Ohki T, et al. Among authors: uchino k. Am J Gastroenterol. 2013 Aug;108(8):1305-13. doi: 10.1038/ajg.2013.109. Epub 2013 Apr 30. Am J Gastroenterol. 2013. PMID: 23629602 Free PMC article. Clinical Trial.
726 results